Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Lessons Learned in Creating Biomedical Nanoparticles for Human Use

Abstract:
Over the past six years, the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), a key component of the NCI's Alliance for Nanotechnology in Cancer, has characterized more than 250 different nanomaterials developed by over 75 research groups. This extensive experience has given NCL staff a unique perspective on how to design safe and biocompatible nanomaterials for human use. In a paper published in the journal Integrative Biology, the NCL team shared some of the lessons they have learned.

Lessons Learned in Creating Biomedical Nanoparticles for Human Use

Bethesda, MD | Posted on August 21st, 2012

The NCL performs and standardizes the pre-clinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The Lab serves as a national resource and knowledge base for cancer researchers, and facilitates the development and translation of nanoscale particles and devices for clinical applications. Scott McNeil, the NCL's director, and seven colleagues compiled the common pitfalls that nonmaterial developers encounter on their path from basic research, to products that will be tested as agents for imaging or delivering drugs to tumors in humans.

One important lesson for nanomaterial developers, who tend to be academic researchers with little experience developing products intended for clinical use, is that they need to focus more on ensuring that the materials they develop for testing in animals, and eventually humans, are sterile. A recent review of 75 samples arriving at the NCL for testing found that more than one-third showed evidence of bacterial contamination.

Another important lesson was that commercially available materials, whether they are nanomaterials or chemicals used to make nanomaterials, are not always what they appear to be. In some cases, these raw materials are contaminated with bacterial toxins, in other cases the products do not meet the specifications advertised by the manufacturers. Dr. McNeil and his colleagues note that "it is in the researchers' best interest to always characterize materials before proceeding with synthesis and more expensive functionalization and biological testing."

NCL staff also found that investigators need to do a better job purifying their nanomaterials of residue remaining from the processes they use to manufacture their nanoparticles and other formulations. In some cases, nanomaterials that appeared to be toxic were in fact biocompatible. Instead, it was production impurities that were causing toxicity issues. Additionally, NCL studies have shown that nanomaterial toxicity can often be eliminated by choosing slightly different starting materials that are incorporated into the final product but that do not play a role as an imaging agent or anticancer drug.

The last two lessons have to do with the importance of developing the right methods for assessing a nanomaterial's stability in the body and the rate at which it releases its cargo at the intended target, the tumor. NCL team leaders recommend that nanomaterial developers employ multiple assays before beginning animal studies to determine these characteristics of their nanomaterials because single assays can often paint an incomplete picture that can lead to wasted time and money.

####

About The National Cancer Institute (NCI)
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © The National Cancer Institute (NCI)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract - “Common pitfalls in nanotechnology: lessons from the NCI’s Nanotechnology Characterization Laboratory.”

Related News Press

News and information

Using ultrathin sheets to discover new class of wrapped shapes: UMass Amherst materials researchers describe a new regime of wrapped shapes August 31st, 2015

New material science research may advance tech tools August 31st, 2015

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Govt.-Legislation/Regulation/Funding/Policy

An engineered surface unsticks sticky water droplets August 31st, 2015

New material science research may advance tech tools August 31st, 2015

Seeing quantum motion August 30th, 2015

Artificial leaf harnesses sunlight for efficient fuel production August 30th, 2015

Nanomedicine

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs August 29th, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

Discoveries

Using ultrathin sheets to discover new class of wrapped shapes: UMass Amherst materials researchers describe a new regime of wrapped shapes August 31st, 2015

An engineered surface unsticks sticky water droplets August 31st, 2015

New material science research may advance tech tools August 31st, 2015

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Announcements

Using ultrathin sheets to discover new class of wrapped shapes: UMass Amherst materials researchers describe a new regime of wrapped shapes August 31st, 2015

An engineered surface unsticks sticky water droplets August 31st, 2015

New material science research may advance tech tools August 31st, 2015

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Safety-Nanoparticles/Risk management

Warning to DIY enthusiasts & construction workers as dangerous dust emissions August 19th, 2015

Bionic liver micro-organs explain off-target toxicity of acetaminophen (Tylenol): Israeli-German partnership aims to replace animal experiments with advanced liver-on-chip devices August 17th, 2015

Sediment dwelling creatures at risk from nanoparticles in common household products August 13th, 2015

Proving nanoparticles in sunscreen products August 4th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic